Phone: 612-624-5551
unews@umn.edu
24-hr number: 612-293-0831

Advanced Search

Expert Alert.

Expert Alert

U of M experts available throughout Diabetes Awareness Month

November 7, 2012

MINNEAPOLIS / ST. PAUL (11/07/2012) – During the month of November, to assist members of the media working on diabetes-related stories to coincide with Diabetes Awareness Month, University of Minnesota physicians and researchers are available to share their expertise around a disease that affects 1 in 3 adults and 1 in 6 youth in Minnesota.

The following University of Minnesota diabetes exerts are available to the media:

Elizabeth Seaquist, M.D., professor, Department of Medicine, Division of Endocrinology and Diabetes, Medical School
Improving the lives of people with diabetes is the ultimate goal of Seaquist’s research. Her experimental work looks at the effect of diabetes on brain metabolism, structure, and function. She is currently heading projects to learn how the brain adapts to diabetes and recurrent hypoglycemia with the long term goal of developing new therapies for the disease.

John Bantle, M.D., professor, director, Division of Endocrinology and Diabetes, Medical School
Bantle has a long-standing interest in diabetes and nutrition and has evaluated the effects of dietary carbohydrates on glycemia and lipemia in diabetic subjects. Recently, his focus has shifted to methods to accomplish weight loss as primary treatment for overweight and obese subjects with Type 2 diabetes. Bantle is also co-principal investigator of a study to assess long-term effects of weight loss on cardiovascular events and diabetes complications in overweight and obese patients with Type 2 diabetes.

David A. Bernlohr, Ph.D., professor, College of Biological Sciences, Medical School
Bernlohr holds the Cargill Chair in Systems Biology and studies inflammation and obesity as determinants in the development of Type 2 diabetes and atherosclerosis.  His work has profiled the role(s) of fatty acid binding proteins in cellular metabolism and their contributions to inflammation and metabolic disease.  More recently his work has emphasized the covalent modification of proteins by reactive lipids and their influence on mitochondrial metabolism and signaling. 

Toni Moran, M.D., professor of pediatrics, division chief, Division of Endocrinology and Diabetes, Medical School

Moran is a principal investigator for the TrialNet diabetes prevention study, and as part of that network is participating in several trials to prevent or ameliorate new onset Type 1 diabetes. Moran has worked for the last 5 years in East Africa to set up pediatric diabetes programs and train health professionals in pediatric diabetes.

Robert Straka, Pharm.D., professor and department head, Experimental and Clinical Pharmacology, College of Pharmacy
Straka’s research interests are focused on optimizing the use of therapeutic agents used for the prevention and treatment of cardiovascular disease. Additionally, Straka can discuss pharmacotherapy as it relates to patients with diabetes and pharmacotherapy of treating hypertension in patients with diabetes.

Mark A. Pereira, Ph.D., associate professor, Program Director of Public Health Nutrition, Division of Epidemiology & Community Health, School of Public Health

Pereira’s area of research focuses on the lifestyle and biological determinants of Type 2 diabetes with an emphasis on prevention, locally and globally.

David Jacobs, professor, Division of Epidemiology & Community Health, School of Public Health
Jacobs focuses on nutrition, cardiovascular disease and diabetes. Jacobs can discuss ways to maintain a healthy lifestyle, diet predicting diabetes, pollutants predicting diabetes and ways to maintain good glucose control past diagnosis.

Diane Treat-Jacobson, Ph.D., R.N., associate professor, School of Nursing

Treat-Jacobson primarily works with patients with peripheral artery disease and diabetes is a risk factor for development of peripheral artery disease. Other specialty areas include outcomes of exercise training in patients with claudication from peripheral artery disease; quality of life assessment in patients with peripheral artery disease; and quality of life measurement.

To schedule an interview with a diabetes expert, contact Matt DePoint, Academic Health Center, (612) 625-4110 or mdepoint@umn.edu.

Expert Alert is a service provided by the University News Service. Delivered regularly, Expert Alert is designed to connect university experts to today's breaking news and current events. For an archive and other useful media services, visit umn.edu/news. Views expressed by experts do not necessarily represent the views of the University of Minnesota.

Tags: Academic Health Center

Share This Story